PHBID.US NeoRich BioPharma Tech Co., Limited

Healthcare Drug Manufacturers - Specialty & Generic USA Stocks
0.4500 USD
Close of Sep 10, 2026
0.1315 7.00
Market cap
USD 156K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2022.

Is PHBID.US undervalued?

Graham number

The Graham number of NeoRich BioPharma Tech Co., Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NeoRich BioPharma Tech Co., Limited fundamental analysis

No fundamental analysis for NeoRich BioPharma Tech Co., Limited yet.

NeoRich BioPharma Tech Co., Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NeoRich BioPharma Tech Co., Limited

NeoRich BioPharma Tech Co., Limited operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for culti…

Full company profile